Mucositis clinical trials

Explore recruiting mucositis clinical trials.

Recruiting mucositis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Mucositis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Comparison of esketamine mouthwash versus intravenous administration for the treatment of chemotherapy/radiotherapy-induced mucositis

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Semaglutide Treatment for Prevention of Toxicity in High-dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation – a randomized, double-blind, placebo-controlled, investigator-initiated study

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase II, Randomized, Open-Label Study Evaluating Two Inavolisib Dose Levels in Combination with Fulvestrant in Participants with PIK3CA-Mutated, HR-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer

Belgium, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

MucPreDex: Radiation-induced MUCositis PREvention using DEXpanthenol mouth rinse

Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Total Neoadjuvant Therapy for lymph node-positive adenocarcinoma of the OESophagus and oesophagogastric junction: TNT-OES-2 trial

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Folic acid supplement versus placebo for treating mucositis adverse events in metastatic renal cell carcinoma patients receiving targeted therapy (FASTERCC)

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Mucositis trials by city

Mucositis in Toronto Mucositis in Vancouver Mucositis in Montreal Mucositis in Calgary Mucositis in Edmonton Mucositis in Ottawa Mucositis in Winnipeg Mucositis in Quebec City Mucositis in Hamilton Mucositis in Kitchener Mucositis in London Mucositis in Halifax Mucositis in New York Mucositis in Los Angeles Mucositis in Chicago Mucositis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease